Objective Evidence from animal studies, case reports, and phase I studies suggests that
hemopoietic stem cell transplantation (HSCT) can be effective in the treatment of rheumatoid …

OBJECTIVE: Since 1996, autologous hemopoietic stem cell transplantation (HSCT) has
been used to treat severe rheumatoid arthritis (RA). To date, published reports have been …

Background Initial results from the ongoing GALLIUM trial have shown that patients with
follicular lymphoma have a longer progression-free survival after first-line immunochemotherapy …

Steroid-refractory acute graft versus host disease (AGVHD) and chronic graft versus host
disease (CGVHD) after allogeneic haematopoietic stem cell transplantation are major causes …

The value of administering sequential courses of chemotherapy containing high-dose cytarabine
in both induction and consolidation therapy for acute myeloid leukemia (AML) has not …

OBJECTIVE: To determine patients’ information, emotional and support needs at the completion
of treatment for a haematological malignancy. METHODS: A self-report questionnaire …

Memory B cell defects underlying the increased susceptibility to infection by encapsulated
bacteria have been examined in allogeneic haematopoetic stem cell transplant (HSCT) …

Purpose: Marizomib (NPI-0052) is an irreversible proteasome inhibitor, derived from a marine
actinomycete, with activity and specificity that is distinct from other proteasome inhibitors. …

Abstract 302 Background: Marizomib has a novel, non-peptide based, bicyclic structure and
compared to other proteasome inhibitors, unique properties of clinical relevance. Specifically…

The randomized phase III ADMYRE trial evaluated plitidepsin plus dexamethasone (DXM)
versus DXM alone in patients with relapsed/refractory multiple myeloma after at least three …